Business
Commercialisation Agreement
Cambridge Cognition Holdings plc has partnered with Ivory to commercialize its CANTAB Pathway™ digital cognitive assessments across India's healthcare and consumer health markets, targeting a population of approximately 1.47 billion, including an estimated 34 million individuals aged over 60 who may have cognitive impairment. This strategic expansion leverages Ivory's brain health platform and distribution network to address a significant unmet need for early cognitive screening in a growing, health-conscious, and tech-enabled demographic estimated between 90-190 million people. The agreement aims to improve early identification and proactive brain health management through scalable, validated digital tools. Disclaimer*
About this update from Cambridge Cognition Holdings Plc
[{"type":"text","content":"\n\n16 February 2026\n \nCambridge Cognition partners with Ivory\nto scale early cognitive screening with CANTAB Pathway™ in India\n \nBengaluru, India and Cambridge, United Kingdom: Cambridge Cognition Holdings plc (\"Cambridge Cognition\") (AIM: COG), the neuroscience technology company specialising in digital cognitive assessments, and Ivory, a venture-backed brain health company headquartered in India, announce an agreement for the commercialisation of CANTAB Pathway™ across the healthcare and consumer health markets in India.\nHighlights\n· Ivory will deploy CANTAB Pathway™ across both professional healthcare and consumer health segments in India\n· Of India's population of approximately 1.47 billion, estimates indicate that 138 million people are aged over 60, and as many as 34 million may be living with mild or major cognitive impairment\n· India's middle and affluent class, estimated to be 90-190 million people, is believed to have an increasing interest in longevity, healthspan, and access to high-quality healthcare \n \nThis partnership represents an important strategic step in Cambridge Cognition's expansion into high-growth international healthcare and consumer markets, leveraging Ivory's rapidly scaling brain health platform and distribution network.\nIndia represents a significant growth opportunity with a population of approximately 1.47 billion. Recent research estimated that among India's 138 million people aged over 60, as many as 34 million may be living with mild or major cognitive impairment (Gross et al., PLOS One, LASI-DAD study).\nRob Baker, Chief Executive Officer - Cambridge Cognition, said, \"India represents a major opportunity, with a significant unmet need for earlier identification of cognitive impairment. As health-conscious, tech-enabled populations grow, demand for proactive brain health tools is increasing rapidly.\nWe believe the Ivory team shares our passion and energy to make a difference and has made impressive progress across both consumer and professional healthcare markets. We are excited to partner with them to expand access to CANTAB Pathway™ in India.\"\nIvory recently published India's first-of-its-kind Brain Health Report, providing new insights into the country's cognitive wellbeing landscap...